DOCGO INC (DCGO)
US2560861096 - Common Stock
We assign a fundamental rating of 5 out of 10 to DCGO. DCGO was compared to 113 industry peers in the Health Care Providers & Services industry. DCGO is in great health and has no worries on liquidiy or solvency at all, but the profibility rating is only average. DCGO is not valued too expensively and it also shows a decent growth rate.
1. Profitability
1.1 Basic Checks
In the past year DCGO was profitable.
In the past year DCGO had a positive cash flow from operations.
In multiple years DCGO reported negative net income over the last 5 years.
In the past 5 years DCGO reported 4 times negative operating cash flow.
1.2 Ratios
The Return On Assets of DCGO (6.24%) is better than 88.50% of its industry peers.
DCGO has a better Return On Equity (9.48%) than 77.88% of its industry peers.
DCGO has a Return On Invested Capital of 8.61%. This is amongst the best in the industry. DCGO outperforms 83.19% of its industry peers.
DCGO had an Average Return On Invested Capital over the past 3 years of 4.74%. This is below the industry average of 8.10%.
The 3 year average ROIC (4.74%) for DCGO is below the current ROIC(8.61%), indicating increased profibility in the last year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 6.24% | ||
| ROE | 9.48% | ||
| ROIC | 8.61% |
ROA(3y)5.95%
ROA(5y)N/A
ROE(3y)8.58%
ROE(5y)N/A
ROIC(3y)4.74%
ROIC(5y)N/A
1.3 Margins
With an excellent Profit Margin value of 4.44%, DCGO belongs to the best of the industry, outperforming 82.30% of the companies in the same industry.
DCGO's Operating Margin of 7.50% is fine compared to the rest of the industry. DCGO outperforms 76.11% of its industry peers.
DCGO has a Gross Margin of 34.50%. This is in the better half of the industry: DCGO outperforms 63.72% of its industry peers.
DCGO's Gross Margin has declined in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 7.5% | ||
| PM (TTM) | 4.44% | ||
| GM | 34.5% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-2.01%
GM growth 5YN/A
2. Health
2.1 Basic Checks
DCGO has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
The number of shares outstanding for DCGO has been increased compared to 1 year ago.
The debt/assets ratio for DCGO is higher compared to a year ago.
2.2 Solvency
DCGO has an Altman-Z score of 3.68. This indicates that DCGO is financially healthy and has little risk of bankruptcy at the moment.
DCGO's Altman-Z score of 3.68 is fine compared to the rest of the industry. DCGO outperforms 78.76% of its industry peers.
The Debt to FCF ratio of DCGO is 1.02, which is an excellent value as it means it would take DCGO, only 1.02 years of fcf income to pay off all of its debts.
Looking at the Debt to FCF ratio, with a value of 1.02, DCGO belongs to the top of the industry, outperforming 91.15% of the companies in the same industry.
A Debt/Equity ratio of 0.12 indicates that DCGO is not too dependend on debt financing.
DCGO has a Debt to Equity ratio of 0.12. This is in the better half of the industry: DCGO outperforms 71.68% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.12 | ||
| Debt/FCF | 1.02 | ||
| Altman-Z | 3.68 |
ROIC/WACC1
WACC8.61%
2.3 Liquidity
A Current Ratio of 2.19 indicates that DCGO has no problem at all paying its short term obligations.
The Current ratio of DCGO (2.19) is better than 78.76% of its industry peers.
A Quick Ratio of 2.19 indicates that DCGO has no problem at all paying its short term obligations.
The Quick ratio of DCGO (2.19) is better than 79.65% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.19 | ||
| Quick Ratio | 2.19 |
3. Growth
3.1 Past
DCGO shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 262.50%, which is quite impressive.
Looking at the last year, DCGO shows a very strong growth in Revenue. The Revenue has grown by 30.17%.
DCGO shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 87.90% yearly.
EPS 1Y (TTM)262.5%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%0%
Revenue 1Y (TTM)30.17%
Revenue growth 3Y87.9%
Revenue growth 5YN/A
Sales Q2Q%-25.66%
3.2 Future
Based on estimates for the next years, DCGO will show a very strong growth in Earnings Per Share. The EPS will grow by 44.02% on average per year.
Based on estimates for the next years, DCGO will show a decrease in Revenue. The Revenue will decrease by -9.46% on average per year.
EPS Next Y280.94%
EPS Next 2Y41.07%
EPS Next 3Y44.02%
EPS Next 5YN/A
Revenue Next Year0%
Revenue Next 2Y-18.36%
Revenue Next 3Y-9.46%
Revenue Next 5YN/A
3.3 Evolution
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
DCGO is valuated correctly with a Price/Earnings ratio of 14.21.
Based on the Price/Earnings ratio, DCGO is valued cheaper than 85.84% of the companies in the same industry.
When comparing the Price/Earnings ratio of DCGO to the average of the S&P500 Index (28.96), we can say DCGO is valued rather cheaply.
DCGO is valuated quite expensively with a Price/Forward Earnings ratio of 29.58.
Compared to the rest of the industry, the Price/Forward Earnings ratio of DCGO is on the same level as its industry peers.
The average S&P500 Price/Forward Earnings ratio is at 23.82. DCGO is valued slightly more expensive when compared to this.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 14.21 | ||
| Fwd PE | 29.58 |
4.2 Price Multiples
96.46% of the companies in the same industry are more expensive than DCGO, based on the Enterprise Value to EBITDA ratio.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of DCGO indicates a rather cheap valuation: DCGO is cheaper than 91.15% of the companies listed in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 9.76 | ||
| EV/EBITDA | 4.95 |
4.3 Compensation for Growth
DCGO's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as DCGO's earnings are expected to grow with 44.02% in the coming years.
PEG (NY)0.05
PEG (5Y)N/A
EPS Next 2Y41.07%
EPS Next 3Y44.02%
5. Dividend
5.1 Amount
DCGO does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
DOCGO INC
NASDAQ:DCGO (11/21/2024, 8:22:06 PM)
After market: 4.02 -0.1 (-2.43%)4.12
+0.02 (+0.49%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap420.45M
Analysts
Price Target
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 14.21 | ||
| Fwd PE | 29.58 | ||
| P/S | |||
| P/FCF | |||
| P/OCF | |||
| P/B | |||
| P/tB | |||
| EV/EBITDA |
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)0.05
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 6.24% | ||
| ROE | 9.48% | ||
| ROCE | |||
| ROIC | |||
| ROICexc | |||
| ROICexgc | |||
| OM | 7.5% | ||
| PM (TTM) | 4.44% | ||
| GM | 34.5% | ||
| FCFM |
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover1.41
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.12 | ||
| Debt/FCF | |||
| Debt/EBITDA | |||
| Cap/Depr | |||
| Cap/Sales | |||
| Interest Coverage | |||
| Cash Conversion | |||
| Profit Quality | |||
| Current Ratio | 2.19 | ||
| Quick Ratio | 2.19 | ||
| Altman-Z |
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
High Growth Momentum
Growth
EPS 1Y (TTM)262.5%
EPS 3YN/A
EPS 5Y
EPS Q2Q%
EPS Next Y280.94%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)30.17%
Revenue growth 3Y87.9%
Revenue growth 5Y
Sales Q2Q%
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y